ANGEL GULLEY: Open Payments
NPI 1073159984 · MARION, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$176 in 10 payments from 7 companies in 2025. Trend: 2023 $1,098 · 2024 $560 · 2025 $176
Food & beverage: $176
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $81 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Dexcom, Inc. | 1 | $16 |
| Novo Nordisk Inc | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| Ascensia Diabetes Care Us Inc. | 1 | $14 |
Products named: UBRELVY, QULIPTA, Kerendia, Dexcom G6 Transmitter, Ozempic, The Cologuard Plus Collection Kit, AIRSUPRA.
Industry payments across AR — which companies pay providers there.
